Data as of:
brimindinvest.com / compare / cat-vs-emrLIVE
CAT
Caterpillar Inc. · Industrials / Heavy Machinery
$821.58
-0.04% this month
VERSUS
COMPARE
EMR
Emerson Electric Co. · Industrials / Automation
$158.23
-0.04% this month
Comparison scoreboard
CAT LEADS 3/5
AI Scorei
CAT ✓68.2
EMR 51.9
1Y Returni
CAT ✓+74.88%
EMR +19.94%
Fwd P/Ei
CAT 24.75
EMR ✓21.42
Target Up.i
CAT ✓+21.91%
EMR +10.72%
Op. Margini
CAT 22.18%
EMR ✓26.92%
Metrics last refreshed: 9/27/2026
Quick take

CAT vs EMR Stock Comparison: AI Score, Valuation, Performance and Upside

ShareXLinkedInRedditFacebookWhatsApp

CAT and EMR both sell into industrial capital spending but at different layers. Caterpillar sells the physical machines that move earth and generate power, with aftermarket service as its recurring layer. Emerson sells the control systems, instruments, and software that run process plants, with a growing recurring software component. Machines against the intelligence that operates plants.

Use this CAT vs EMR comparison to compare the quality of each recurring revenue stream. Caterpillar's comes from parts and service on machines, which is durable but tied to equipment in the field. Emerson's comes from installed control systems and software subscriptions, which is stickier still because replacing a plant's control layer is genuinely disruptive.

Live analysis · updated 9/27/2026

CAT holds the edge across 3 of 5 key metrics in this comparison. CAT has delivered stronger 1-year price return (+74.88% vs +19.94%), though EMR has the better forward P/E setup (21.42x vs 24.75x for CAT). On fundamentals, CAT is growing revenue faster (24.00%), while EMR maintains the higher operating margin (26.92%) — a classic growth-versus-profitability split. Analyst consensus implies meaningfully more upside for CAT (+21.91%) than for EMR (+10.72%).

Want a full valuation workup? 46-section report — AI Score, Monte Carlo forecast, bull/bear case, DCF, and more.
Normalized 1Y performance
CAT
EMR
Recent returns
CAT
EMR
Analyst price targets & sentiment

Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.

CAT · 25 analysts
STRONG BUYHOLDSTRONG SELL
Buy (2.1/5.0)
14 Buy / 12 Hold / 2 Sell
Price target range
analyst low$283.00
analyst mean$975.61
current price$821.58
+21.9% upside to analyst mean
EMR
Price target range
analyst mean$171.81
current price$158.23
+10.7% upside to analyst mean
Who should consider this stock?
CAT may suit investors who:
  • Want direct exposure to construction, mining, and power generation demand
  • Value the aftermarket parts and service cushion
  • Prefer an established dividend growth and buyback record
  • Accept pronounced cyclicality in equipment orders
EMR may suit investors who:
  • Want automation exposure with growing recurring software revenue
  • Value the stickiness of installed process control systems
  • Support the portfolio refocus toward automation
  • Accept dependence on energy and chemical project spending plus software integration risk
Performance & AI score
Performance & AI score
MetricCATEMR
AI scorei68.251.9
AI ranki#48#374
Latest closei$821.58$158.23
1M returni-0.04%-0.04%
6M returni+18.14%+26.18%
1Y returni+74.88%+19.94%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

$10,000 invested — hypothetical growth (dividends reinvested)
PeriodCATEMR
1Y ago$17.72K (+77.2%)
started 2025-09-25
$12.16K (+21.6%)
started 2025-09-25
5Y ago$47.69K (+376.9%)
started 2021-09-27
$19.24K (+92.4%)
started 2021-09-27
10Y ago$154.1K (+1441.0%)
started 2016-09-26
$49.48K (+394.8%)
started 2016-09-26

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
Valuation & upside potential
MetricCATEMR
Market capi$367.85B$86.56B
Trailing P/Ei34.4834.03
Forward P/Ei24.7521.42
Price/Salesi2.63N/A
EV/Revenuei5.455.27
Analyst targeti$975.61$171.81
Target upsidei+21.91%+10.72%
Growth, profitability & risk
Growth, profitability & risk
MetricCATEMR
Revenue growthi24.00%7.00%
Earnings growthi68.20%23.00%
EPS growthi+68.20%+23.00%
FCF margini+6.76%+19.89%
Operating margini22.18%26.92%
Profit margini14.51%13.83%
ROIC proxyi56.97%12.80%
Return on equityi56.97%12.80%
Dividend yieldi0.80%1.43%
Payout ratioi26.01%47.98%
Dividend growth streakiNo increase yetNo increase yet
Betai1.601.24
Debt/equityi232.7867.68
Current ratioi1.370.90
Quick ratioi0.780.62
Correlation

Over the past year, CAT and EMR have moved moderately in the same direction (correlation of 0.58), based on daily returns.

1Y
0.58
-1.0+1.0
5Y
0.64
-1.0+1.0
10Y
0.69
-1.0+1.0
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
CAT max drawdowni26.83%
EMR max drawdowni23.74%
CAT max wkly dropi11.99%
EMR max wkly dropi8.22%
5Y risk snapshot
CAT max drawdowni34.05%
EMR max drawdowni29.61%
CAT max wkly dropi17.13%
EMR max wkly dropi15.00%
10Y risk snapshot
CAT max drawdowni43.36%
EMR max drawdowni50.77%
CAT max wkly dropi24.36%
EMR max wkly dropi28.66%
Performance metrics by period
Performance metrics by period
PeriodMetricCATEMR
1YGrowthi+77.17%+21.61%
CAGRi+77.32%+21.65%
Volatilityi39.79%31.90%
Sharpe ratioi1.530.63
Sortino ratioi2.410.91
Max drawdowni26.83%23.74%
Current drawdowni22.85%3.74%
Avg drawdowni7.35%8.06%
Ulcer Indexi11.01%9.98%
Max daily dropi6.91%6.26%
Max wkly dropi11.99%8.22%
5YGrowthi+342.07%+77.10%
CAGRi+34.66%+12.12%
Volatilityi31.75%27.76%
Sharpe ratioi0.960.39
Sortino ratioi1.450.56
Max drawdowni34.05%29.61%
Current drawdowni22.85%3.74%
Avg drawdowni8.76%8.48%
Ulcer Indexi11.68%10.40%
Max daily dropi8.64%8.65%
Max wkly dropi17.13%15.00%
10YGrowthi+1126.52%+285.20%
CAGRi+28.50%+14.44%
Volatilityi31.47%29.27%
Sharpe ratioi0.810.46
Sortino ratioi1.190.65
Max drawdowni43.36%50.77%
Current drawdowni22.85%3.74%
Avg drawdowni10.69%9.23%
Ulcer Indexi13.93%11.97%
Max daily dropi14.28%18.96%
Max wkly dropi24.36%28.66%
AI Prediction Signali
Members only
Next 5 trading days
CAT
+2.8%BUY
EMR
+1.1%HOLD
Next 30 trading days
CAT
+6.4%BUY
EMR
+3.2%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Business comparison
Business comparison
CategoryCATEMR
CompanyCaterpillar Inc.Emerson Electric Co.
SectorIndustrialsIndustrials
IndustryFarm & Heavy Construction MachinerySpecialty Industrial Machinery
Core businessManufacturer of construction and mining equipment and of engines, turbines, and generator sets, distributed through independent dealers who also supply parts and service. Includes a captive finance arm.Industrial automation company focused on process and hybrid industries, providing control systems, measurement instruments, valves, and industrial software after reshaping its portfolio around automation and divesting consumer-facing businesses.
Investor focusConstruction and mining capital spending, dealer inventories, power generation demand, services revenue, and pricing versus costs.Underlying orders and backlog, process automation project activity, software attach and recurring revenue, segment margins, and integration of acquired software assets.
CAT strengths
  • Large installed base generating durable aftermarket parts and service revenue
  • Exposure to power generation demand from data centers and industrial users
  • Strong free cash flow with a long record of dividend growth and buybacks
EMR strengths
  • Installed control systems create long-lived customer relationships and recurring aftermarket demand
  • Industrial software adds higher-margin recurring revenue to a hardware base
  • Portfolio now focused on automation rather than spread across unrelated businesses
Risks to watch — CAT
  • Highly cyclical equipment demand linked to commodities and construction
  • Dealer inventory swings obscure the underlying demand picture
  • Exposed to tariffs, freight, and input cost inflation across a global footprint
Risks to watch — EMR
  • Large process automation projects depend on energy and chemical capital spending cycles
  • Software acquisitions carry integration risk and were expensive
  • Short-cycle discrete automation demand has been uneven
Frequently asked questions
It is the control and measurement layer that runs continuous industrial operations such as refineries, chemical plants, and water treatment facilities, deciding how valves, pumps, and reactions are managed moment to moment. Emerson supplies the control systems, instruments, and software for this, which is why its customer relationships last decades: the control layer is tied to plant safety and uptime.
Interactive comparison engine

Compare more than two at a time

This page is a fixed writeup on CAT and EMR. Our comparison engine is the interactive version: load up to five tickers, switch timeframes, and get the correlation, drawdown, and overlap analysis that a static page can't show.

Up to 5 tickers at once

Add three more names beside CAT and EMR, mixing stocks and ETFs in the same table — useful when the real question is which of a whole peer group to own.

Scoreboard verdict

AI score, forward P/E, analyst target upside, operating margin, and revenue growth are scored head-to-head, with a running tally of which ticker leads on how many metrics.

Full risk suite

Volatility, Sharpe and Sortino ratios, maximum, current, and average drawdown, Ulcer Index, and worst single-day and single-week drops across every timeframe.

Correlation heatmap

Pairwise daily-return correlation for every combination, so you can see whether two holdings actually diversify each other or just move together.

Valuation vs profitability

A scatter plot of forward P/E against return on equity, plus drawdown and 30-day rolling volatility charts, to separate what is cheap from what is merely beaten down.

Holdings overlap and CSV export

For ETFs, a top-holdings comparison that exposes hidden overlap between funds. Every comparison exports to CSV for your own spreadsheet work.

Two comparisons a week are free without an account. A 14-day trial removes the limit and adds AI price forecasts, stock rankings, saved watchlists, and the intrinsic value calculator — no credit card required.

Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

In-Depth Reports

Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.

Related comparisons
More comparisons
Browse all 1,000 comparisons
ShareXLinkedInRedditFacebookWhatsApp